Page 2 of 2
- Open access and open source in chemistry
MH Todd; Chem Cent J. 2007; 1: 3.
- Open biotechnology: licenses needed
Y. Joly; Nature Biotechnology, Vol. 28, 417-419, 2010.
- Open Source Drug Discovery in Practice: A Case Study
Årdal C, Røttingen JA.
PLoS Negl Trop Dis. 2012 Sep;6(9):e1827. doi: 10.1371/journal.pntd.0001827. Epub 2012 Sep 20.
- Open Source Drug Discovery: Finding A Niche (Or Maybe Several)
SM Maurer. 2007.
- Open Source for Neglected Diseases: Magic Bullet or Mirage
Masum H. and Harris R. 2011. The Results for Development Institute, Washington D.C.
- Open-Minded to Open Innovation and Precompetitive Collaboration
J A Wagner; Clinical Pharmacology & Therapeutics 87, 511-515 (May 2010).
- Opinion: The future of pharmaceutical R&D: somewhere between open and reverse innovation?
Talaga, P. (2010) Future Medicinal Chemistry, Vol. 2(9), 1399-1403.
- Partnerships for Innovation and Global Health: NIH International Technology Transfer Activities
L.A.Salicrup, M.L.Rohrbaugh; IP Handbook of Best Practices- Putting Intellectual Property to Work: Experiences from Around the World.
- Pools, thickets and Open Source Nanotechnology
J. D'Silva; European Intellectual Property Review, Vol. 31, No. 6, pp. 300-306, 2006.
- Resolving the open source paradox in biotechnology: A proposal for a revised open source policy for publicly funded genomic databases
D.M. Gitter; Computer Law & Security Report; Volume 24, Issue 6, 2008, Pages 529-539.
- ROLE OF OPEN INNOVATION MODELS AND IPR IN TECHNOLOGY TRANSFER IN THE CONTEXT OF CLIMATE CHANGE MITIGATION
In DIFFUSION OF RENEWABLE ENERGY TECHNOLOGIES: CASE STUDIES OF ENABLING FRAMEWORKS IN DEVELOPING COUNTRIES - TECHNOLOGY TRANSFER PERSPECTIVE SERIES, (Eds), J. Haselip, I. Nygaard, U. Hansen, E. Ackom, eds., UNEP Riso Centre, Denmark, 2011 pp. 147-158
- Synthetic Biology: Caught between Property Rights, the Public Domain, and the Commons
Rai A, Boyle J (2007) Synthetic Biology: Caught between Property Rights, the Public Domain, and the Commons. PLoS Biol 5(3).
- The Bayh-Dole Model in Developing Countries: Reflections on the Indian Bill on Publicly Funded Intellectual Property
UNCTAD - ICTSD Policy Brief No. 5 By Bhaven N. Sampat.
- The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery
J. Weigelt; EMBO reports 10, 941 - 945 (September 2009).
- The Genetic Code is 3.6 Billion Years Old: It’s Time for a Rewrite': Questioning the Metaphors and Analogies of Synthetic Biology and Life Science Patenting
by Graham Dutfield
This chapter is about science, patent law and the use of language that supports the extension of patent claims ever deeper into the realms of nature. By language I refer in particular to the use of figures of speech, terminologies and epistemologies that both express and support powerful explanatory and justificatory conceptual systems. Undoubtedly, chemical, informational and mechanistic ways of understanding life have all been enormously helpful to scientists, as are the metaphors and analogies which frame their verbal and written forms of expression. The point of the chapter is not to undermine them, but to examine critically what implications they have for patent law and policy, in particular their consequences for the positioning of boundaries between the patentable and the unpatentable. NB These are uncorrected proofs.